150 related articles for article (PubMed ID: 30527382)
21. Sclerotherapy followed by surgery for the treatment of oral hemangioma: a report of two cases.
Mariano FV; Vargas PA; Della Coletta R; Lopes MA
Gen Dent; 2011; 59(3):e121-5. PubMed ID: 21903533
[TBL] [Abstract][Full Text] [Related]
22. Sclerotherapy as an esthetic indication in oral vascular malformations: a case series.
Manzano BR; Premoli AM; Santaella NG; Ikuta CRS; Rubira CMF; Santos PSDS
An Bras Dermatol; 2019; 94(5):521-526. PubMed ID: 31777351
[TBL] [Abstract][Full Text] [Related]
23. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate.
Choi YH; Han MH; O-Ki K; Cha SH; Chang KH
J Vasc Interv Radiol; 2002 May; 13(5):475-82. PubMed ID: 11997355
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Ethanolamine Oleate Sclerotherapy in Treatment of Peripheral Giant Cell Granuloma.
Said Ahmed W
J Oral Maxillofac Surg; 2016 Nov; 74(11):2200-2206. PubMed ID: 27235183
[TBL] [Abstract][Full Text] [Related]
25. Hemorrhagic duodenal varices treated successfully with endoscopic injection sclerotherapy using cyanoacrylate and ethanolamine-oleate: a case report.
Suzuki R; Irisawa A; Hikichi T; Shibukawa G; Takagi T; Wakatsuki T; Imamura H; Takahashi Y; Sato A; Sato M; Ikeda T; Tasaki K; Obara K; Ohira H
Surg Laparosc Endosc Percutan Tech; 2009 Dec; 19(6):e233-6. PubMed ID: 20027076
[TBL] [Abstract][Full Text] [Related]
26. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
[TBL] [Abstract][Full Text] [Related]
27. Ethanolamine oleate sclerotherapy versus simple cyst aspiration in the management of orbitopalpebral cyst associated with congenital microphthalmos.
Naik MN; Honavar SG; Murthy RK; Raizada K; Thomas R
Ophthalmic Plast Reconstr Surg; 2007; 23(4):307-11. PubMed ID: 17667104
[TBL] [Abstract][Full Text] [Related]
28. Monoethanolamine oleate sclerotherapy for the treatment of intraoral vascular anomalies: retrospective study and suggestion for a clinical guideline.
Tolentino ES; Faria LO; Vargas RM; Camarini C; Santin GC; Chicarelli da Silva M
Br J Oral Maxillofac Surg; 2020 May; 58(4):416-420. PubMed ID: 32057469
[TBL] [Abstract][Full Text] [Related]
29. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.
Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
J Vasc Surg; 2008 Mar; 47(3):578-84. PubMed ID: 18295109
[TBL] [Abstract][Full Text] [Related]
30. Real-time MRI-guided percutaneous sclerotherapy treatment of venous low-flow malformations in the head and neck.
Partovi S; Lu Z; Vidal L; Nakamoto DA; Buethe J; Coffey M; Patel IJ
Phlebology; 2018 Jun; 33(5):344-352. PubMed ID: 28516809
[TBL] [Abstract][Full Text] [Related]
31. Oral vascular malformation in a patient with hereditary hemorrhagic telangiectasia: a case report.
Hopp RN; de Siqueira DC; Sena-Filho M; Jorge J
Spec Care Dentist; 2012; 32(1):11-4. PubMed ID: 22229593
[TBL] [Abstract][Full Text] [Related]
32. Monoethanolamine Oleate Sclerotherapy for Polycystic Liver Disease.
Takita M; Iwanishi M; Minami T; Kono M; Chishina H; Arizumi T; Yada N; Hagiwara S; Minami Y; Ida H; Ueshima K; Naoshi N; Kudo M
Dig Dis; 2016; 34(6):654-658. PubMed ID: 27750233
[TBL] [Abstract][Full Text] [Related]
33. Extravascular injection of sclerotic agents does not affect vessels in the rat: experimental implications for percutaneous sclerotherapy of arteriovenous malformations.
Sato D; Kurita M; Ozaki M; Kaji N; Takushima A; Harii K
Eur J Vasc Endovasc Surg; 2012 Jul; 44(1):73-6. PubMed ID: 22546640
[TBL] [Abstract][Full Text] [Related]
34. Mucosal varicosities: case report treated with monoethanolamine oleate.
Gomes CC; Gomez RS; do Carmo MA; Castro WH; Gala-García A; Mesquita RA
Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E44-6. PubMed ID: 16388293
[TBL] [Abstract][Full Text] [Related]
35. [Ethanolamine oleate as a sclerosing solution in the therapy of esophageal varices].
Tsutsumi M; Takada A
Nihon Rinsho; 1990 Apr; 48(4):713-7. PubMed ID: 2366357
[No Abstract] [Full Text] [Related]
36. Five adult laryngeal venous malformation cases treated effectively with sclerotherapy.
Kamijo A; Hatsushika K; Kanemaru S; Moriyama M; Kase Y; Masuyama K
Laryngoscope; 2013 Nov; 123(11):2766-9. PubMed ID: 23553378
[TBL] [Abstract][Full Text] [Related]
37. Ethanolamine oleate in resistant idiopathic achalasia: a novel therapy.
Niknam R; Mikaeli J; Mehrabi N; Mahmoudi L; Elahi E; Shirani S; Malekzadeh R
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1111-5. PubMed ID: 21971376
[TBL] [Abstract][Full Text] [Related]
38. Ultrasound follow-up of ethanolamine oleate sclerotherapy for spermatoceles.
Mattila SI; Tammela TL; Mäkäräinen HP; Hellström PA
Eur Urol; 1993; 23(3):361-5. PubMed ID: 8508888
[TBL] [Abstract][Full Text] [Related]
39. Sclerotherapy for lymphatic malformations of the head and neck in the pediatric population.
Tu JH; Do HM; Patel V; Yeom KW; Teng JMC
J Neurointerv Surg; 2017 Oct; 9(10):1023-1026. PubMed ID: 27707871
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of sclerotherapy of benign oral vascular lesions with monoethanolamine oleate.
da Silva Barros CC; Campos CM; de Morais Medeiros HC; Queiroz LMG; da Silveira ÉJD
Clin Oral Investig; 2021 Apr; 25(4):1767-1774. PubMed ID: 32748074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
